Market Value549,036,939
Total Holdings42
File Date2023-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
KRTX / Karuna Therapeutics, Inc.
VKTX / Viking Therapeutics, Inc.
TERN / Terns Pharmaceuticals, Inc.
ANAB / AnaptysBio, Inc.
SRPT / Sarepta Therapeutics, Inc. Put
ACRS / Aclaris Therapeutics, Inc. Put
XENE / Xenon Pharmaceuticals Inc. Put
MLYS / Mineralys Therapeutics, Inc.
GBIO / Generation Bio Co.
APLS / Apellis Pharmaceuticals, Inc. Put
TVTX / Travere Therapeutics, Inc.
ICPT / Intercept Pharmaceuticals Inc
PNT / POINT Biopharma Global Inc.
MRTX / Mirati Therapeutics, Inc.
REPL / Replimune Group, Inc.
SLDB / Solid Biosciences Inc.
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
RPHM / Reneo Pharmaceuticals, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
TALS / Talaris Therapeutics Inc
EOLS / Evolus, Inc.
PTCT / PTC Therapeutics, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
AKRO / Akero Therapeutics, Inc.
ALKS / Alkermes plc
MCRB / Seres Therapeutics, Inc.
PLRX / Pliant Therapeutics, Inc.
DTIL / Precision BioSciences, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
HRTX / Heron Therapeutics, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
INSM / Insmed Incorporated
ALPN / Alpine Immune Sciences, Inc.
OPTN / OptiNose, Inc.
SRPT / Sarepta Therapeutics, Inc.
ITCI / Intra-Cellular Therapies, Inc.
MRSN / Mersana Therapeutics, Inc. Call
AMAM / Ambrx Biopharma Inc. Call
ACRS / Aclaris Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
RAPT / RAPT Therapeutics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
AVTE / Aerovate Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
ZURA / Zura Bio Limited
AMLX / Amylyx Pharmaceuticals, Inc.
APGE / Apogee Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
GOSS / Gossamer Bio, Inc.
IGMS / IGM Biosciences, Inc.
FOLD / Amicus Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc. Call
URGN / UroGen Pharma Ltd.
ACLX / Arcellx, Inc.